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Abstract
Background: Zirconium nanoparticles are used as health agents, pharmaceutical
carriers, and in dental and orthopedic implants.
Objective: This studyaimed to investigate the effects of Zirconium oxide nanoparticles
on the process of spermatogenesis in rat.
Materials and Methods: In this experimental study, 32 male Wistar rats (150-200
gr), with range of age 2.5 to 3 months were used and divided into four groups of
eight per each. The control group received 0.5 ml of distilled water and the three
experimental groups received 50, 200, and 400 ppm doses of Zirconium oxide
nanoparticles solution over a 30-day period, respectively. At the end of the experiment,
tissue sections were taken from the testis and stained with hematoxylin-eosin. Serum
concentration of testosterone was measured by enzyme-linked immunosorbent assay.
Results: In the experimental group receiving 400 ppm Zirconium oxide nanoparticles,
the number of Spermatogonia cells (p≤0.01), Spermatocytes (p≤0.01), Spermatids (p≤
0.001), and sertoli and Leydig cells (p ≤ 0.05) showed a significant decrease compared
to the control group. Serum testosterone concentration did not change significantly
in all experimental groups receiving Zirconium oxide nanoparticles compared to the
control group. Experimental group received 400 ppm Zirconium oxide nanoparticles
shrinkage of seminal tubules and reduced lumen space compared to control group.
Conclusion: Zirconium oxide nanoparticles are likely to damage the testes by
increasing Reactive oxygen species production and free radicals.
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1. Introduction
Nanotechnology refers to the technology of
materials that measure about 1-100 nanometers
(1). The nanoparticles have unique physical and
chemical properties that cannot be seen even
in the materials from which they are derived.
The small size and high surface area of the
nanoparticles increase their chemical activity and
allow them to act as a high performance catalyst
(2).
Since 1960, Zirconium nanoparticles have
been introduced as biomaterials for use in
orthopedics in the form of artificial joints and in
dentistry as coatings, implants, and composites
(3). Zirconium oxide ceramic nanostructures have
also been widely used in drug transducers as
drug carriers for several drugs such as Myconazol,
Pennyceline, Alendronit, and Zolendronitthat (4,
5). Zirconium nanoparticles have been shown
to cause significant DNA damage (6) and
mesenchymal stem cell death (7) and inhibit
cell proliferation in rodent fibroblast cell lineages
(8).
While a study by Demir and co-worker showed
that Zirconium oxide nanoparticles lead to gene
toxicity in peripheral blood lymphocytes and
cultured renal embryonic cells (9), a study by Ye
and co-worker found that high concentrations of
Zirconium oxide nanoparticles induce cell death
and morphological changes in cultured 3T3-E1
cells. In addition, zirconium oxide nanoparticles
induced osteogenic differentiation (10). A study by
Gad and co-worker showed that Zirconium oxide
nanoparticles have antifungal activity against
Candida albicans (11).
Moreover, in a study by Banerjee and co-worker,
it was found that Zirconium oxide nanoparticles
have antimicrobial activity (12), and Atalay and
co-worker in 2018 reported that Zirconium
oxide nanoparticles induce DNA damage and
cell death in L929 mouse fibroblast cell liners
(13). While Arefian and co-worker reported in
their study that Zirconium oxide nanoparticles
had strong toxic effects on liver and kidney
factors (14) Omidi and co-worker showed that
zirconium oxide nanoparticles at a dose of
400 ppm resulted in a significant decrease in
Luteinizing hormone (LH), Follicle-stimulating
hormone (FSH), and testosterone in female rats
(15).
Recent reports indicate that many nanoparticles
have harmful or toxic effects on spermatogenesis.
In contrast, some nanoparticles have a non-
toxic effect on spermatogenesis. These
reports indicate that animal species, drug use,
nanoparticle dosage and its characteristics
including size, shape, chemical composition,
surface area, and surface charge play an
important role in determining the effect of
nanoparticles on spermatogenesis. How
nanoparticles penetrate into the blood-testicular
barrier plays a crucial role in explaining the
toxicity of nanoparticles on spermatogenesis
(16).
According to our best knowledge, there is no
study that investigate the effect of Zirconium oxide
nanoparticles on spermatogenesis and serum
levels of testosterone in rats. Similarly, there
has been no study to evaluate the effect of
Zirconium oxide nanoparticles on testicular germ
cells and seminal tubular epithelium in rats for
30 days. Due to the role of Zirconium oxide
nanoparticles in the production and growth of
free radicals, it is likely that these nanoparticles
may have pathological effects on the structure
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of seminal vesicles and consequently decrease
sperm quality and fertility. In this study, we
investigated the possible effect of Zirconium oxide
nanoparticles prepared by the Tecnan company
manufactured in Spain (CAS#1314-23-4) on serum
levels of testosterone and spermatogenesis in
adult rat.
2. Materials and Methods
2.1. Animals
In this experimental study, 32 adult (2.5-3
month) male Wistar rats weighing approximately
150-200 gr were used. Animals were kept under
the same conditions at temperatures of 20-22°C
for 12 hr light/dark cycle. The animals were
provided with adequate water and food and
ethical considerations were observed.
2.2. Animal treatment
The animals were divided into four groups
of eight animals. Control group: received
0.5 ml of sterile distilled water. Experimental
group (I): received 50 ppm Zrconium oxide
nanoparticlessolution.
Experimental group (II): received 200
ppm Zirconium oxide nanoparticles solution.
Experimental group (III): received 400 ppm
Zirconium oxide nanoparticles solution. All
solutions were given daily for 30 days orally (15).
Animals body weight was measured using digital
scales at the end of the experiment and were
anesthetized with ether.
Blood samples were taken from the left
ventricle of the heart, and the samples were kept
in laboratory conditions for 20min and centrifuged
at 3000 rpm for 10 min. Then, the serum of
each tube was collected. Serum concentrations of
testosterone were determined by enzyme-linked
immunosorbent assay.
2.3. Histological tests
After the animals were sacrificed, their left
testicles were removed. At the fixation stage, the
tissues were fixed in 10% buffered formalin. The
dehydration step was performed with the help
of alcohol at different concentrations (from low
to high). The clearing step was performed by
placing the tissues in two containers containing
xylene. In the replacement phase, tissues were
placed in three containers of molten paraffin
(65°C) for 1 hr. In the molding phase, the
parts of Salto Kohart were used. At the cross-
section, tissue sections were cut to 4-5 μm in
thickness and hematoxylin-eosin dye for staining.
All tissue studies were performed under the
supervision of a pathologist. Tissue sections
were morphometrically examined and imaged
by a Dino-Eye-AM 423 camera. In each slide,
four points were randomly selected and the
walls of seminiferous tubules and the diameter
of seminiferous tubules were morphometrically
measured. At least five seminiferous tubules
were selected from each slide. Numbers of
spermatogonia, spermatocytes, spermatids,
Sertoli and Leydig cells present in lumen were
compared between different groups (17).
In this study, 14 nm zirconium nanoparticles
(Figure 1) were used which were determined by X-
ray diffraction methods and Transmission Electron
Microscopy (TEM) and determination of extraction
impurities by ICP-MS technique was 99/993%
(Figure 2) (18, 19).
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Figure 1. Transmission Electron Microscopy (TEM) micrograph of nanoscale zirconium dioxide suspended in media and dispersed
by an ultrasonic bath (19).
Figure 2. Diffractogram X-ray powder diffraction (XRD) of nanoparticles of zirconium oxide used in this experiment. The horizontal
axis on theta -scale show angle between X radiancy and reflect. The vertical axis shows intensity of radiancy (19).
2.4. Ethical consideration
All experiments were conducted according to
the protocol provided by the ethics committee
of Islamic Azad University Arsanjan Branch
(IR.IAU.A.REC.1397.001).
2.5. Statistical analysis
Data were analyzed using the Statistical
Package for the Social Sciences (SPSS software,
Chicago, Illinois), version 18.0., analysis of variance
(ANOVA) and Tukey Test. Statistical inference
boundary was statistically significant for the
experimental groups receiving different amounts
of zirconium oxide nanoparticles at P ≤ 0.05 level
compared to the control group. In this study, the
results of experiments performed along with the
relevant statistical calculations are presented in
the form of graphs.
3. Results
While the mean body weights in the
experimental groups (I) and (II) did not change
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significantly compared to control group, the
mean body weight in the experimental group (III)
significantly decreased compared to the control
group (p ≤ 0.05, Figure 3).
The mean testicular weight in all experimental
groups receiving different amounts of zirconium
oxide nanoparticles did not change significantly
compared to the control group (Figure 4).
Interestingly, while the average number of
spermatogonial cells in the experimental groups
(I) and (II) did not change significantly compared
to the control group, the average number of
spermatogonial cells in the experimental group (III)
decreased significantly compared to the control
group (p ≤ 0.01) (Figure 5).
Further, although the average number of
spermatocyte cells in the experimental groups
(I) and (II) did not change significantly compared
to the control group, the average number of
spermatocyte cells in the experimental group (III)
decreased significantly compared to the control
group (p ≤ 0.01) (Figure 5).
However, the average number of spermatid cells
in all experimental groups (I), (II) and (III) significantly
decreased compared to the control group (p ≤
0.0001, respectively) (Figure 6).
As for the Leydig cells, the average number
of Leydig cells in the experimental groups (I) and
(II) did not change significantly compared to the
control group. However, the average number of
Leydig cells in experimental group (III) decreased
significantly compared to the control group (p ≤
0.05, Figure 7).
Further, the average number of Sertoli cells
in the experimental groups (I) and (II) also did
not change significantly compared to the control
group. However, the average number of Sertoli
cells in the experimental group (III) decreased
significantly compared to the control group (p ≤
0.05, Figure 7).
The mean serum testosterone concentration
in all experimental groups receiving different
amounts of zirconium oxide nanoparticles did not
change significantly compared to the control group
(Figure 8).
3.1. Results of testicular tissue studies
There were no pathological changes in testicular
photomicrographs of the control group and
testicular tubules, and germ cells appeared normal
(Figure 9).
In the experimental group (I), recipients of
zirconium oxide nanoparticles (50 ppm) showed a
decrease in the density of different types of germ
cells compared to the control group (Figure 10).
In the experimental group (II), recipients of
zirconium oxide nanoparticles (200 ppm) showed
better shrinkage of seminiferous tubules and
decreased number of germ cells, especially
spermatid cells, compared to the control group
(Figure 11).
In the experimental group (III) showed a
sharp decrease in the number of seminiferous
tubules. The irregularity and disruption of
the germinal epithelium and shrinkage of the
tubules were visible. In addition, Spermatogonia,
Spermatocytes, Spermatids, Sertoli and Leydig
cells were noticeable in the lumen. Therefore,
tissue degradation is clearly observed in this
experimental group (Figure 12).
In the experimental groups receiving different
amounts of Zirconium oxide nanoparticles, the
number of spermatogonia, primary spermatocytes,
and spermatids decreased compared to the
control group. These effects are dose dependent
and in the receiving group the maximum
amount of Zirconium oxide nanoparticles (400
ppm) is higher than the other experimental
groups.
https://doi.org/10.18502/ijrm.v13i9.7671 Page 769
International Journal of Reproductive BioMedicine Mehdikhani et al.
Figure 3. Comparison of the mean body weight in different groups. The presence of at least one similar letter is indicative of no
significant difference between the groups. Lack of similar letter between the groups indicates significant difference at the level of
P ≤ 0.05. Values are shown as Mean ± SEM.
Figure 4. Comparison of the mean testicular weight in different groups. The presence of at least one similar letter is indicative
of no significant difference between the groups. Lack of similar letter between the groups indicates significant difference at the
level of P ≤ 0.05. Values are shown as Mean ± SEM.
Figure 5. Comparison of the mean spermatocyte and spermatigonia cells count in different groups. The presence of at least one
similar letter is indicative of no significant difference between the groups. Lack of similar letter between the groups indicates
significant difference at the level of P ≤ 0.05. Values are shown as Mean ± SEM.
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Figure 6. Comparison of the mean spermatid cells count in different groups. The presence of at least one similar letter is indicative
of no significant difference between the groups. Lack of similar letter between the groups indicates significant difference at the
level of P ≤ 0.05. Values are shown as Mean ± SEM.
Figure 7. Comparison of the mean Sertoli and leydig cells count in different groups. The presence of at least one similar letter is
indicative of no significant difference between the groups. Lack of similar letter between the groups indicates significant difference
at the level of P ≤ 0.05. Values are shown as Mean ± SEM.
Figure 8. Comparison of the mean testosterone concentration in different groups. The presence of at least one similar letter is
indicative of no significant difference between the groups. Lack of similar letter between the groups indicates significant difference
at the level of P ≤ 0.05. Values are shown as Mean ± SEM.
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Figure 9. Photomicrograph of the testes in the control group. Staining: Hematoxylin and eosin (H & E), magnification ’100.
Figure 10. Photomicrograph of the testes in the experimental group (I) (the experimental group received 50 ppm of zirconium
oxide nanoparticles). Staining: H & E, magnification ’100.
Figure 11. Photomicrograph of the testes in the experimental group (II) (the experimental group received 200 ppm of zirconium
oxide nanoparticles). Staining: H & E, magnification ×100.
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Figure 12. Photomicrograph of the testes in the experimental group (III) (the experimental group received 400 ppm of zirconium
oxide nanoparticles). Staining: H & E, magnification ×100.
4. Discussion
The mean body weight in the experimental
group receiving 400 ppm zirconium oxide
nanoparticles decreased significantly compared
to the control group (p ≤ 0.05). These results are
in line with a 2010 study by Kim and co-worker,
where it was shown that the administration of 500
mg/kg of silver nanoparticles orally for 13 weeks
in male mice resulted in lower body weight and
increased blood cholesterol levels (20).
The mean testicular weight in all experimental
groups receiving different amounts of zirconium
oxide nanoparticles did not change significantly
compared to the control group. A study by Fan
and co-worker showed that exposure to mice
with silicon oxide nanoparticles resulted in a
significant decrease in testicular weight. Silicon
oxide nanoparticles are likely to reduce the
testicular weight of rat by oxidative damage to the
testes by increasing ROS (reactive oxygen species)
(21).
The average number of Sertoli cells in the
experimental group receiving 400 ppm zirconium
oxide nanoparticles decreased significantly
compared to the control group (p ≤ 0.05). A
2013 study by Talebi and co-worker showed that
zinc oxide nanoparticles damage Sertoli cells.
The mechanism of the effects of nanoparticles
on the testes of mice is not known. Zinc oxide
nanoparticles are likely to have deleterious effects
on Sertoli cell function through the formation
of multinuclear giant cells, increasing vacuoles
in Sertoli cells. The results of this study were
consistent with the results of the study (22). Also,
Braydich-Stolle and co-worker showed that silver
nanoparticles decrease ATP levels in Sertoli cells
by reducing FYN/Kinase enzyme levels in Sertoli
cells. Silver nanoparticles appear to damage
the Sertoli cells and the germ cells by reducing
the amount of FYN/Kinase enzyme followed by
ATP depletion. Silver nanoparticles can disrupt
Sertoli cell damage by inhibiting Glial cell-derived
neurotrophic factor (GDNF) signaling pathway,
which is secreted from Sertoli cells, resulting in a
proliferation of spermatogonial cells (23).
Further, the average number of Leydig
cells in the experimental group receiving 400
ppm zirconium oxide nanoparticles decreased
significantly compared to the control group (p ≤
0.05). These results are consistent with the study of
Talebi and co-worker (22). The results in their study
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showed that silver nanoparticles can affect Leydig
cells and testosterone inhibitor synapses, and the
number of Leydig cells was significantly reduced
in the groups treated with silver nanoparticles (20).
Omidi and co-worker investigated the effect
of zirconium nanoparticles on testosterone, LH,
and FSH in female rat. Zirconium nanoparticles
led to a significant decrease in plasma levels of
testosterone in female rat (15). Testosterone is
higher in the male than in the female. In a recent
study, the dose of zirconium oxide nanoparticles
used was not sufficient to influence testosterone
levels in male rats. Therefore, in all groups the level
of testosterone decreased but this decrease was
not significant (p ≤ 0.05).
Jia and co-worker reported that titanium
dioxide nanoparticles significantly reduced
serum testosterone levels and expression
in rat testes. Titanium dioxide nanoparticles
decreased the expression of 17 beta-hydroxy
steroids dehydrogenase and P 450 17 alpha-
hydroxysteroid dehydrogenase and increased
the expression of cytochrome P 450-19 (key
enzyme for translating testosterone to estradiol)
in mice. Titanium dioxide nanoparticles at the
translational level cause changes in testosterone.
In addition, titanium dioxide nanoparticles may
reduce spermatogenesis by reducing serum
testosterone synthesis (24). Due to similarities
in zirconium and titanium nanoparticles in their
properties, a decrease in serum testosterone level
was observed in male rats treated with zirconium
nanoparticle oxide, but this decrease was not
significant.
Other researchers have shown that
nanoparticles lead to the decline of germ
cells. Miresmaeili et al. reported that silver
nanoparticles led to a significant decrease in the
number of spermatogonia, primary spermatocytes,
spermatids, and spermatozoa (25).
Lan and Yang showed that nanoparticles are
capable of crossing the blood-testicular barrier,
thereby exerting inflammatory effects on testicular
tissue. The nanoparticles do not directly destroy
the nucleus membrane. Nanoparticles first affect
the cytoskeleton. They then destroy the nucleus
membrane. In addition, the nanoparticles may be
endocytosed by sex cells or Leydig cells, causing
changes in inflammation in the cell and then
exocytosis (16).
Cellular and tissue damage can be caused by
the extensive production of ROS in inflammatory
diseases (26). In addition, increasing ROS
production can lead to increased production
of external cytokines and further damage (27).
Various studies have shown that zirconium
nanoparticles can lead to increased production
of ROS and increased caspase-3, mitochondrial
membrane potential, and DNA strand breaks.
Zirconium nanoparticles can cause cellular toxicity
by causing mitochondrial damage (28, 13).
Studies have shown that exposure to zirconium
oxide nanoparticles resulted in a significant
decrease in Glutathione peroxidase (GPx) in rat.
In fact, the imbalance between the production of
free radicals and their ability to detoxify by GPx
in the molecular mechanism of toxicity causes
cell damage (29, 30, 31). Concerning the results, it
seems that irconium oxide nanoparticles decrease
spermatogenesis through the mechanisms
described. It is also possible that zirconium oxide
nanoparticles may decrease spermatogenesis by
reducing serum testosterone synthesis.
5. Conclusion
Studies have shown that zirconium oxide
nanoparticles can damage testicular tissue, which
is dose-dependent. In addition, the doses of
zirconium oxide nanoparticles in this study did
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not lead to a significant change in the serum
concentration of testosterone.
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